Edition:
United States

Synergy Pharmaceuticals Inc (SGYP.OQ)

SGYP.OQ on NASDAQ Stock Exchange Global Select Market

1.42USD
19 Oct 2018
Change (% chg)

$-0.05 (-3.40%)
Prev Close
$1.47
Open
$1.47
Day's High
$1.51
Day's Low
$1.42
Volume
575,781
Avg. Vol
652,617
52-wk High
$3.18
52-wk Low
$1.28

Chart for

About

Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide. The Company is engaged in the discovery, research and development efforts around analogs of uroguanylin... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $364.54
Shares Outstanding(Mil.): 247.99
Dividend: --
Yield (%): --

Financials

  SGYP.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.64 -- --
ROI: -245.92 1.96 12.83
ROE: -- 1.12 14.95

BRIEF-Synergy Pharmaceuticals Reports Q1 Loss Per Share $0.15

* SYNERGY PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

May 10 2018

Earnings vs. Estimates